FANCELLI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 349
NA - Nord America 318
AS - Asia 153
AF - Africa 1
Totale 821
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 317
IE - Irlanda 94
IT - Italia 90
HK - Hong Kong 58
PL - Polonia 54
RU - Federazione Russa 42
SE - Svezia 39
CN - Cina 31
JO - Giordania 29
SG - Singapore 20
IN - India 12
AT - Austria 9
CH - Svizzera 5
NO - Norvegia 5
GB - Regno Unito 4
DE - Germania 3
FR - Francia 2
VN - Vietnam 2
CA - Canada 1
EG - Egitto 1
FI - Finlandia 1
TR - Turchia 1
UA - Ucraina 1
Totale 821
Salva come PNG Salva come JPEG
Città #
Dublin 94
Warsaw 52
Hong Kong 44
Chandler 40
Ashburn 36
Fairfield 30
Woodbridge 17
Florence 15
Seattle 15
Cambridge 14
Altamura 13
Shanghai 13
Singapore 13
Lawrence 12
Moscow 12
Boardman 10
Houston 10
Milan 10
Wilmington 10
Vienna 9
New York 8
Beijing 7
Pune 7
Princeton 6
Boston 5
Los Angeles 5
Oslo 5
Bern 4
Kent 4
Andover 3
Ann Arbor 3
Hillsboro 3
London 3
Mumbai 3
Norwalk 3
Recanati 3
San Diego 3
Anguillara Sabazia 2
Bremen 2
Chennai 2
Dong Ket 2
Falls Church 2
Livorno 2
Paris 2
Rome 2
Rufina 2
Venice 2
Acerra 1
Ancona 1
Bagno A Ripoli 1
Bari 1
Buffalo 1
Chicago 1
Krefeld 1
Lappeenranta 1
Marcallo con Casone 1
Medford 1
Padova 1
Phoenix 1
Verona 1
Wandsworth 1
Washington 1
Zurich 1
Totale 580
Salva come PNG Salva come JPEG
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 155
TAS-102 in gastric cancer: Development and perspectives of a new biochemically modulated fluroropyrimidine drug combination 67
Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment 58
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 57
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 57
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 55
REBECA trial: A new piece of the evidence for bevacizumab in platinum-resistant recurrent ovarian cancer 47
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 37
Results of the observational prospective RealFLOT study 37
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 36
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 30
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 28
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 28
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 26
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 25
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients 23
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 21
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 18
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 15
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 15
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 15
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 4
null 3
Totale 857
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.332
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.332
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202061 0 3 4 3 9 6 6 6 6 5 9 4
2020/202196 5 9 0 30 4 3 3 9 8 8 5 12
2021/202237 0 2 3 0 0 4 4 4 1 3 3 13
2022/2023308 10 36 7 27 14 53 50 39 44 7 11 10
2023/2024264 11 14 22 11 24 40 17 60 2 14 24 25
2024/202571 53 18 0 0 0 0 0 0 0 0 0 0
Totale 857